semaglutide indication FDA has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) for long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for Wegovy vs. Ozempic: What To

received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, Novo Nordisk, Novartis, Pfizer and Sanofi

The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications

Key takeaways: 27% of respondents noticed changes to their menstrual cycle since starting GLP-1 medication for weight loss Respondents with PCOS were more likely to experience cycle changes, and 43% of this group reported noticing changes to their menstrual cycle The most commonly reported cycle changes were more predictable periods, more frequent periods, and shorter periods GLP-1 medications like semaglutide (Ozempic) and tirzepatide (Mounjaro) have traditionally been used to treat diabetes

They can be effective, but the effects are not specific to the immune system and can cause problems with virtually every system in the body (Barshes, 2004)

Q: Is Neurobion Forte RF Injection suitable for children

The risk of side effects can be higher in people with certain medical conditions